Partnerships, Licensing, Investments and M&A Deals and Trends for July 2016 in Pharmaceuticals

Date: September 1, 2016
Pages: 97
Price:
US$ 1,000.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P7EA66C44ABEN
Leaflet:

Download PDF Leaflet

Partnerships, Licensing, Investments and M&A Deals and Trends for July 2016 in Pharmaceuticals

SUMMARY

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for July 2016 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in July 2016. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary

SCOPE
  • Analysis of the market trends for the pharmaceutical industry in the global arena.
  • Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
  • Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
  • Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
  • Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
  • Analysis of partnership and licensing deals based on clinical stage of development of products.
  • Summary of the pharmaceutical deals globally in the six months.
  • Information on the top deals happened in the pharmaceutical industry.
  • Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
  • League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
REASONS TO BUY
  • Enhance your decision making capability in a more rapid and time sensitive manner.
  • Find out the major deal performing segments for investments in your industry.
  • Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
  • Identify companies that are aggressively looking to raise capital in the market
  • Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
  • Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
  • Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
  • Identify growth segments and opportunities in each region within the industry.
  • Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 PHARMACEUTICALS & HEALTHCARE, GLOBAL, DEAL SUMMARY

2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, July 2016
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, July 2016
  2.2.1 Teva Pharma Raises USD15 Billion in Public Offering of Notes
  2.2.2 Teva Pharma Raises USD4.4 Billion in Additional Public Offering of Notes
  2.2.3 Celgene Enters into Agreement with Jounce Therapeutics
  2.2.4 Galenica to Acquire Relypsa for USD1.53 Billion in Tender Offer
  2.2.5 AstraZeneca to Enter into Co-Marketing Agreement with Aspen
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, July 2016
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, July 2016

3 PHARMACEUTICALS AND HEALTHCARE, GLOBAL, DEALS, SUMMARY, BY TYPE

3.1 Pharmaceuticals & Healthcare, Global, M&A, July 2016
  3.1.1 Top M&A Deals in July 2016
  3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, February 2016 - July 2016
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, July 2016
  3.2.1 Top Equity Offering Deals in July 2016
  3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, February 2016 - July 2016
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, July 2016
  3.3.1 Top PE/VC Deals in July 2016
  3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, July 2016
  3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, July 2016
  3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, February 2016-July 2016
  3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, February 2016-July 2016
3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, July 2016
3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, February 2016 - July 2016
3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), July 2016
  3.6.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, July 2016
3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), February 2016 - July 2016
3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, February 2016 - July 2016
3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), February 2016 - July 2016
3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), February 2016 - July 2016

4 PHARMACEUTICALS & HEALTHCARE, GLOBAL, LICENSING AGREEMENTS, JULY 2016

4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, July 2016
4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), July 2016
4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), February 2016 - July 2016
4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), February 2016 - July 2016
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), February 2016 - July 2016
4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), February 2016 - July 2016
  4.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, July 2016
  4.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, July 2016
  4.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, July 2016

5 PHARMACEUTICALS & HEALTHCARE, GLOBAL, DEAL SUMMARY BY THERAPY AREA

5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, July 2016
  5.1.1 Oncology - Deals of the Month
5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, July 2016
  5.2.1 Central Nervous System - Deals of the Month
5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, July 2016
  5.3.1 Infectious Diseases - Deals of the Month
5.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, July 2016
  5.4.1 Cardiovascular - Deals of the Month
5.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, July 2016
  5.5.1 Immunology - Deals of the Month
5.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, July 2016
  5.6.1 Gastrointestinal - Deal of the Month
5.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, July 2016
  5.7.1 Metabolic Disorders - Deal of the Month

6 DEAL SUMMARY BY GEOGRAPHY

6.1 Pharmaceuticals & Healthcare, North America Deals, July 2016
  6.1.1 North America - Deals of the Month
6.2 Pharmaceuticals & Healthcare, Europe, Deals, July 2016
  6.2.1 Europe - Deals of the Month
6.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, July 2016
  6.3.1 Asia-Pacific - Deals of the Month
6.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, July 2016
  6.4.1 Rest of the World - Deals of the Month

7 PHARMACEUTICALS & HEALTHCARE, GLOBAL, TOP FINANCIAL ADVISORS

7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, February 2016 - July 2016
7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, February 2016 - July 2016

8 FURTHER INFORMATION

8.1 Methodology
8.2 About GlobalData
8.3 Disclosure information
8.4 Disclaimer

LIST OF TABLES

Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, July 2016
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), July 2016
Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, July 2016
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, February 2016 - July 2016
Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, July 2016
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 11: Pharmaceuticals & Healthcare, Global, Top PE/VC Deals, July 2016
Table 12: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Deals Summary, February 2016 - July 2016
Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals and Deal Values (%), July 2016
Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, February 2016 - July 2016
Table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), February 2016 - July 2016
Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Values (US$ m), July 2016
Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), February 2016 - July 2016
Table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, February 2016 - July 2016
Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal values (US$ m), February 2016 - July 2016
Table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront and Milestone Payments and Deal Values (US$ m), February 2016 - July 2016
Table 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments (US$ m), July 2016
Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, February 2016 - July 2016
Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), July 2016
Table 29: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Value, July 2016
Table 30: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payments, July 2016
Table 31: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, July 2016
Table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 35: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 37: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 38: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 39: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 40: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 41: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 42: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Table 44: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), February 2016 - July 2016

LIST OF FIGURES

Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), July 2016
Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), July 2016
Figure 4: Pharmaceuticals & Healthcare, Global, M&As, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 5: Pharmaceuticals & Healthcare, Global, M&As by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, February 2016 - July 2016
Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 8: Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 9: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, February 2016 - July 2016
Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%), July 2016
Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Deal Values (%), July 2016
Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 13: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), February 2016 - July 2016
Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), February 2016 - July 2016
Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, February 2016 - July 2016
Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, February 2016 - July 2016
Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), February 2016 - July 2016
Figure 20: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 21: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), February 2016 - July 2016
Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), February 2016 - July 2016
Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals, February 2016 - July 2016
Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Deal Values (US$ m), February 2016 - July 2016
Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payments and Deal Values (US$ m), July 2016
Figure 27: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 28: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 29: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 30: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 31: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 32: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 33: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 34: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 35: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 36: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 37: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 38: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Figure 39: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), February 2016 - July 2016
Skip to top


Ask Your Question

Partnerships, Licensing, Investments and M&A Deals and Trends for July 2016 in Pharmaceuticals
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: